Send PM
Followers 7
Posts 517
Boards Moderated 0
Alias Born 03/17/2011

Re: None

Wednesday, 06/15/2022 12:47:39 PM

Wednesday, June 15, 2022 12:47:39 PM

Post# of 3158
Acadia rises as FDA posts briefing docs ahead of AdCom meeting on antipsychotic therapy
The shares of the commercial-stage biotech Acadia Pharmaceuticals (NASDAQ:ACAD) surged ~29% in the Wednesday after the FDA published briefing documents on antipsychotic therapy pimavanserin targeted at patients with Alzheimer’s disease.
A group of independent experts advising the agency are set to meet on Friday to discuss the approvability of the drug as a treatment for hallucinations and delusions associated with Alzheimer’s disease psychosis (ADP).
The FDA's advisory committees issue non-binding recommendations. However, the regulator usually follows them before making a final decision on authorizations.
Pimavanserin is currently marketed as Nuplazid for the treatment of hallucinations and delusions associated with Parkinson’s disease psychosis.
The FDA has assigned an action date for August 04 to review the marketing application for the new indication.  

Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 2M
  • 3M
  • 6M
  • 1Y
  • 2Y
  • 3Y
  • 5Y
Recent ACAD News

Swifty Global Gets Swifty Gaming Off to a Flying Start and Updates its Annual Revenue Target DRCR Oct 3, 2022 10:29 AM

Branded Legacy, Inc. Products Now Featured in New Brick and Mortar Location BLEG Oct 3, 2022 9:26 AM

TNS Reports, These Four Stocks have New Developments that Could Equate to Big Catalysts INND Oct 3, 2022 8:14 AM

TNS Reports on Stocks with Potential Near-Term Catalysts in the Works SYSX Oct 3, 2022 8:08 AM

IGEN's Nimbo Tracking adds four new dealerships and 1250 vehicles across three states in Third Quarter 2022 IGN Oct 3, 2022 6:00 AM

ILUS Confirms Share Lock-Up Opportunity ILUS Sep 29, 2022 1:25 PM

ILUS Appoints Investment Bank to Assist With Up-List and Associated Acquisitions ILUS Sep 29, 2022 11:22 AM

New Break Identifies High-Grade Gold, up to 70.60 g/t Au, via Grab Sampling at Moray NBRK Sep 29, 2022 10:29 AM

Arts & Collectibles DOT Company Coinllectibles Seeing a Very Bright Future with Revenue jumping by 100% to US$8.8 Million in First Half of 2022 as compared to The Year Before COSG Sep 29, 2022 8:44 AM

Rising Star Trillion Energy Ready to Supply Much Needed European Gas TCF Sep 29, 2022 8:00 AM

GBT is researching the Development of Electro-Thermal Aware Design Environment for Integrated Circuits.Seeking to Address Advanced Nanometer Nodes Semiconductors Electro-Thermal Modeling and Optimization. GTCH Sep 29, 2022 7:30 AM

Goldshore Intersects 192.75m @ 1.02 g/t Au from 94.45m depth in MMD-22-051 GSHRF Sep 29, 2022 7:30 AM

SFLMaven Plans for New Potential Revenue from Patent Pending HolgoGlow Technology for the Metaverse SFLM Sep 29, 2022 6:30 AM

Ludwig's genomic-based mRNA Inflammatory Index - a Ground-Breaking Technology LUDG Sep 28, 2022 1:34 PM

Headwater Gold Commences Multi-Rig Drill Program at the Spring Peak Project, Nevada to Follow Up Epithermal Vein Discoveries HWAUF Sep 28, 2022 10:13 AM